Ligand validation:5JBC

0G6: D-phenylalanyl-N-[(2S,3S)-6-{[amino(iminio)methyl]amino}-1-chloro-2-hydroxyhexan-3-yl]-L-prolinamide

0G6 is a Ligand Of Interest in 5JBC designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
5JBC_0G6_S_302	76%	16%	0.112	0.949	2.61	1.14	10	3	0	0	100%	0.9677
5JBA_0G6_S_302	96%	21%	0.065	0.973	1.91	1.4	8	4	0	0	100%	0.9677
5JB9_0G6_S_301	94%	30%	0.063	0.96	1.68	1.11	5	1	0	0	100%	0.9677
4LZ1_0G6_L_301	99%	30%	0.045	0.971	1.29	1.51	3	5	0	0	100%	0.9677
4CH2_0G6_B_1001	96%	38%	0.068	0.975	1.13	1.29	2	4	3	0	100%	0.9677
6EO6_0G6_H_701	96%	44%	0.069	0.976	1.06	1.12	2	5	0	0	100%	0.9677
4I7Y_0G6_H_302	94%	60%	0.065	0.966	0.57	0.95	-	1	0	0	100%	0.9677
6Z8V_0G6_H_301	94%	31%	0.076	0.974	1.21	1.51	2	7	0	0	100%	0.9677

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.